Investigation of the protective effect of erythropoietin on spinal cord injury in rats

Hong,Zhenghua; Hong,Huaxing; Chen,Haixiao; Wang,Zhangfu; Hong,Dun

doi:10.3892/etm.2011.285

Investigation of the protective effect of erythropoietin on spinal cord injury in rats

Authors:
- Zhenghua Hong
- Huaxing Hong
- Haixiao Chen
- Zhangfu Wang
- Dun Hong
View Affiliations

Affiliations: Department of Orthopedics, Taizhou Hospital of Zhejiang Province, Taizhou 317000, P.R. China
Published online on: June 14, 2011 https://doi.org/10.3892/etm.2011.285
Pages: 837-841

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Erythropoietin (EPO) is a promising therapeutic agent used in a variety of spinal cord injuries. Therefore, identifying the specific molecular pathway mediating the neuronal protective effect of EPO after spinal cord injury (SCI) is of great value to the patients concerned. Platelet-derived growth factor (PDGF)-B is an important factor in the recovery of neurological function. We explored changes in the expression of PDGF-B in spinal cord injury rats after receiving EPO treatment. We used a weight-drop contusion SCI model, and EPO treatment group rats received single doses ofEPO (1,000 U/kg i.p.) immediately after the operation. Seven days after the operation, the results revealed a more rapid recovery as noted by the higher BBB scores, less disruption and more neuronal regeneration of the spinal cord in the EPO treatment group than that in the SCI group. PDGF-B expression also increased in the EPO treatment group compared to that in the SCI group (P<0.01). This study showed that PDGF-B plays a role in the neuronal protective effect of EPO on spinal cord injury in rats, which may help to explain the quick recovery after EPO treatment of spinal cord injury.

View Figures

View References

1.	Schmitt C, Miranpuri GS, Dhodda VK, Isaacson J, Vemuganti R and Resnick DK: Changes in spinal cord injury-induced gene expression in rat are strain-dependent. Spine J. 6:113–119. 2006. View Article : Google Scholar : PubMed/NCBI
2.	Hong Z, Chen H, Hong H, Lin L and Wang Z: TSP-1 expression changes in diabetic rats with spinal cord injury. Neurol Res. 31:878–882. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Grasso G, Sfacteria A, Meli F, Fodale V, Buemi M and Iacopino DG: Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res. 1182:99–105. 2007. View Article : Google Scholar : PubMed/NCBI
4.	Hasselblatt M, Ehrenreich H and Siren AL: The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol. 18:132–138. 2006. View Article : Google Scholar : PubMed/NCBI
5.	Ishii Y, Oya T, Zheng L, et al: Mouse brains deficient in neuronal PDGF receptor-beta develop normally but are vulnerable to injury. J Neurochem. 98:588–600. 2006. View Article : Google Scholar : PubMed/NCBI
6.	Bergsten E, Uutela M, Li X, et al: PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol. 3:512–516. 2001. View Article : Google Scholar : PubMed/NCBI
7.	Wu QH, Chen WS, Chen QX, Wang JH and Zhang XM: Changes in the expression of platelet-derived growth factor in astrocytes in diabetic rats with spinal cord injury. Chin Med J (Engl). 123:1577–1581. 2010.PubMed/NCBI
8.	Janmaat ML, Heerkens JL, de Bruin AM, Klous A, de Waard V and de Vries CJ: Erythropoietin accelerates smooth muscle cell-rich vascular lesion formation in mice through endothelial cell activation involving enhanced PDGF-BB release. Blood. 115:1453–1460. 2010. View Article : Google Scholar
9.	Montero M, Poulsen FR, Noraberg J, et al: Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol. 204:106–117. 2007. View Article : Google Scholar
10.	Okutan O, Solaroglu I, Beskonakli E and Taskin Y: Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. J Clin Neurosci. 14:364–368. 2007. View Article : Google Scholar
11.	Grasso G, Sfacteria A, Passalacqua M, et al: Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery. 56:821–827. 2005. View Article : Google Scholar
12.	Adamcio B, Sargin D, Stradomska A, et al: Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biol. 6:372008. View Article : Google Scholar : PubMed/NCBI
13.	King VR, Averill SA, Hewazy D, Priestley JV, Torup L and Michael-Titus AT: Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci. 26:90–100. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Bittorf T, Buchse T, Sasse T, Jaster R and Brock J: Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance. Cell Signal. 13:673–681. 2001. View Article : Google Scholar : PubMed/NCBI
15.	Zhang W, Sun B, Wang X, Liu J, Zhang Z and Geng S: Erythropoietin enhances survival of facial motor neurons by inhibiting expression of inducible nitric oxide synthase after axotomy. J Clin Neurosci. 17:368–371. 2010. View Article : Google Scholar
16.	Enge M, Wilhelmsson U, Abramsson A, et al: Neuron-specific ablation of PDGF-B is compatible with normal central nervous system development and astroglial response to injury. Neurochem Res. 28:271–279. 2003. View Article : Google Scholar : PubMed/NCBI
17.	Yang C, Li B, Liu TS, Zhao DM and Hu FA: Effect of electracupuncture on proliferation of astrocytes after spinal cord injury. Zhongguo Zhen Jiu. 25:569–572. 2005.(In Chinese).
18.	Huang X, Kim JM, Kong TH, et al: GM-CSF inhibits glial scar formation and shows long-term protective effect after spinal cord injury. J Neurol Sci. 277:87–97. 2009. View Article : Google Scholar : PubMed/NCBI
19.	Egawa-Tsuzuki T, Ohno M, Tanaka N, et al: The PDGF B-chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp Neurol. 186:89–98. 2004. View Article : Google Scholar : PubMed/NCBI